Digital Health Acquisition Overview
Digital Health Acquisition (DHAC) has a ROE of -211.26%, below the sector sector average of -4.03%.
Get informed when a big investor buys or sells
+ Follow-211.26%
Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.
Digital Health Acquisition (DHAC) currently reports a ROE of -211.26%. That is below the sector sector average of -4.03%. Use the charts on this page to explore Digital Health Acquisition's ROE history and peer comparisons.
Digital Health Acquisition's ROE of -211.26% is lower than the its sector sector average of -4.03%. That is roughly 5148.6% below the sector mean. A reading lower peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.
There is no universal 'good' ROE, but Digital Health Acquisition's current -211.26% should be judged against industry norms (sector average: -4.03%) and against DHAC's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.
Start with the current ROE of -211.26%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is -4.03%. From there, open related valuation or income-statement pages for Digital Health Acquisition, and consider following DHAC for alerts when major investors trade the stock.
